James Hayward

Applied DNA’s soothing solution to Aloe ‘deception’

By GREGORY ZELLER // In a further display of its unique – some would suggest universal – applicability, Applied DNA Sciences may soon find its way into your favorite facial cream. And maybe your top sports drink, too, now that the surging biotech has engaged new research under a partnership with Lily of the Desert, a leading producer of Aloe vera-derived products including topical creams and nutritional beverages. The Texas-based natural products producer and the…


New federal defense contract bolsters Applied DNA

By GREGORY ZELLER // A new multiyear, seven-figure contract will expand Applied DNA Sciences’ relationship with the Department of Defense. The Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist announced Tuesday that it’s won a two-year, roughly $1.5 million competitive-bid contract through the federal Defense Logistics Agency. The contract, which runs through May 2019, was granted via a Rapid Innovation Fund that provides the DLA with “innovative technologies that can be rapidly inserted into acquisition…


Applied DNA: Cotton, leather and finally making hay

By GREGORY ZELLER // It’s not quite a return to the company’s financial halcyon days, but Applied DNA Sciences may have finally turned a corner. Yes, the Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist ended the second quarter of its fiscal 2017 (ended March 31) with a quarterly net loss of $3.4 million, or 13 cents per share. But it was less of a loss (barely) than the $3.5 million bite suffered in 2Q…


Applied DNA goes ‘Beyond’ in cotton quest

By GREGORY ZELLER // Applied DNA Sciences is going to Bed Bath & Beyond, but not because it needs new towels. Instead, the Stony Brook-based provider of DNA-focused supply chain, anti-counterfeiting and anti-theft technologies, as well as product-genotyping and product-authentication solutions, is incorporating its “textile molecular tag” technology into the national retailer’s Wamsutta line – cotton products that claim to be made exclusively from pure Pima cotton grown in California. Now, thanks to Applied DNA’s…


With unique tech, Applied DNA gets into in vitro

By GREGORY ZELLER // A Stony Brook-based biotech has embarked on a five-year mission to safeguard in vitro diagnostics. In vitro studies, sometimes called “test tube experiments,” involve microorganisms, cells and other biological molecules outside their normal biological context. In the molecular biology era, such tests – performed not only in test tubes but in flasks, petri dishes and other laboratory vessels – have increased in both frequency and importance. Now, Applied DNA Sciences –…


At Applied DNA, they’re really getting into leather

By GREGORY ZELLER // A new international partnership backed by a host of well-known global brands will develop DNA-based security and product-authentication solutions for the leather industries. Stony Brook-based biotech Applied DNA Sciences this week announced a “research agreement” with BLC Leather Technology Centre, a UK-based R&D firm that delivers a range of services to leather suppliers, manufacturers and distributors in some 40 countries. Applied DNA President and CEO James Hayward introduced the program March 30 at…


Debrief: Circular thoughts with James Hayward

When last we Debriefed Applied DNA Sciences CEO James Hayward, the Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication company was forming a promising partnership with a national law-enforcement/security training organization and inching a toe into the Scandinavian auto theft prevention-and-recovery market. This week, as the biotech partners with textile manufacturer Loftex Home to launch the hot new CertainT platform, Hayward reports big gains in those maturing verticals and progress by Applied DNA’s all-star advisory board – two…


Fighting forced labor, Applied DNA forms cotton club

By GREGORY ZELLER // So, where does your cotton come from? Applied DNA Sciences would like you to know. Adding to its portfolio of crimefighting products and services, the Stony Brook-based biotech has identified lead genetic markers unique to cotton cultivars – produced intentionally by genetic breeding – grown in Uzbekistan, where forced human labor is used to harvest the fluffy fiber. Now, the anti-counterfeiting and product-authentication specialist is “seeking out partners” in an effort…


On cotton, new capital and comebacks to come

By GREGORY ZELLER // Capital infusions and superstar strategic advisors couldn’t save Applied DNA Sciences from another bottom-line beating in the first quarter of Fiscal 2017 – but the biotech appears ready to punch back. Reporting Thursday on the quarter ended Dec. 31, the Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist noted $903,000 in quarterly revenues – down 32 percent from the $1.32 million reported in 1Q FY2016, and 45 percent from the $1.64 million reported in 4Q…


Former NYPD commish Kelly joins Applied DNA

By GREGORY ZELLER // Another household name has joined the Applied DNA Sciences advisory board, this time to bulk up the biotech’s law-enforcement vertical. Former New York City Police Commissioner Raymond Kelly, currently vice chairman of New York City-based cyber-intelligence firm K2 Intelligence, has joined the company’s Strategic Advisory Board, Applied DNA said Tuesday. Kelly, the first person to serve two terms as NYPD commissioner and the longest-serving commissioner in department history, brings a wealth…


PepsiCo exec gives Applied DNA another slugger

In another strong recruitment targeting a specific market vertical, Applied DNA Sciences has welcomed PepsiCo’s vice chairman to its Strategic Advisory Board. Mehmood Khan – also a former PepsiCo executive VP and chief scientific officer, as well as CEO of the Westchester County-based international branding titan’s Global Nutrition Group – will lend his expertise as Applied DNA attempts to expand its supply-chain, anti-counterfeiting and anti-theft technologies to the food production, packaging and delivery markets. Khan’s…


Battling European auto thefts, and the bottom line

By GREGORY ZELLER // Holiday gift guide update: The once-mighty “Grand Theft Auto” videogame series no longer cracks most-wanted lists on the top gaming consoles. Newsflash: The real thing has also lost some luster across northwestern Europe, where Applied DNA Sciences’ SmartDNA security solutions are contributing to major vehicular-theft declines – and sending a growing gang of international grand thieves to the clink. On a “quest to protect automobiles in Scandinavia,” the Stony Brook-headquartered provider of DNA-based supply-chain,…


Following big deal, Applied DNA gets defensive

By GREGORY ZELLER // Just a week after closing a $5 million stock deal with a single private investor, Applied DNA Sciences is enlisting big-time with the U.S. military. This week, the Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist announced back-to-back deals for its flagship SigNature DNA product, both with armed-forces implications. The first deal involves microcircuits for the U.S. Defense Logistics Agency, the Department of Defense’s combat logistics command center. The second is…


Applied DNA Sciences lands energy vet Catell

A major-league energy veteran with global pop will help guide Applied DNA Sciences’ approach to power-grid protection. The Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist has appointed Robert Catell to its Board of Directors. It’s a big get for the biotech, which develops and markets botanical-DNA-based security and authentication solutions, and a departure of sorts for Catell, who is arguably known best as the one-time chairman of both KeySpan Corp. and National Grid’s U.S….


Waiting on ginning season, Applied DNA dips

Stony Brook-based Applied DNA Sciences reported another down quarter Thursday, with company officials blaming declines on shifting demands for the biotech’s proprietary security solutions. Reporting results for the third quarter of its fiscal 2016, which ended June 30, the company noted revenues of $653,000, a 71 percent dive from the $2.3 million reported in 3Q FY2015. The lower revenues – which actually bested the $573,000 reported in 2Q FY2016, which ended March 31 – were…